Personnel Announcement

Novo Nordisk Pharma Ltd. (President: Keisuke Kotani, Headquarters: Chiyoda-ku, Tokyo, hereinafter referred to as Novo Nordisk Pharma) announces the following personnel changes.

① Executive Personnel Changes (Effective March 1, 2026) Name New Position Previous Position Ryo Kato (かとう りょう) Head of Medical Policy & Government Affairs Department Manager, Public Affairs Department, Medical Policy & Government Affairs

Name New Position Previous Position Junko McMaster (McMaster Junko) Director, Corporate Affairs Department ―

About Novo Nordisk Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases and improve the lives of people affected by them. To achieve this, we are discovering scientific innovations, expanding access to our medicines, and working to prevent disease and ultimately cure it. Novo Nordisk employs approximately 68,800 people in 80 countries, and its products are sold in about 170 countries. The Japanese subsidiary, Novo Nordisk Pharma Ltd., was established in 1980.